Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlled release of interleukin-2 from biodegradable microspheres.

M S Hora1, R K Rana, J H Nunberg

  • 1Cetus Corporation, Emeryville, CA 94608.

Bio/Technology (Nature Publishing Company)
|August 1, 1990
PubMed
Summary

Biodegradable microspheres offer controlled release of modified interleukin-2 (IL-2). This formulation provides sustained delivery of bioactive polyethylene glycol-modified IL-2 over 20-30 days.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Prevalence of P. malariae in Odisha, India.

Tropical biomedicine·2021
Same author

Wrong-site nerve blocks: 10 yr experience in a large multihospital health-care system.

British journal of anaesthesia·2015
Same author

Successful combined heart-bilateral lung-kidney transplantation from a same donor to treat severe hypertrophic cardiomyopathy with secondary pulmonary hypertension and renal failure: case report and review of the literature.

Transplantation proceedings·2011
Same author

The effect of residual neuromuscular blockade on the speed of reversal with sugammadex.

Anesthesia and analgesia·2009
Same author

Genomic DNA sequence comparison between two inbred soybean cyst nematode biotypes facilitated by massively parallel 454 micro-bead sequencing.

Molecular genetics and genomics : MGG·2008
Same author

Sexual behaviour and condom use among individuals with a history of symptomatic genital herpes.

Sexually transmitted infections·2006

Area of Science:

  • Biomaterials Science
  • Drug Delivery Systems
  • Immunology

Background:

  • Interleukin-2 (IL-2) is a cytokine crucial for immune response.
  • Controlled release systems are needed to optimize IL-2 therapy.
  • Modified IL-2 forms (SIL-2, PEG IL-2) aim to improve stability and efficacy.

Purpose of the Study:

  • To evaluate biodegradable poly(DL-lactide-co-glycolide) microspheres for controlled IL-2 release.
  • To assess the release kinetics and bioactivity of modified IL-2 formulations.
  • To determine the feasibility of using microspheres for sustained delivery of PEG IL-2.

Main Methods:

  • Preparation of biodegradable microspheres encapsulating IL-2 and its modified forms.
  • In vitro release studies to quantify drug release over time.

Related Experiment Videos

  • Bioactivity assays to confirm the functional integrity of released IL-2 variants.
  • Use of human serum albumin (HSA) as an excipient in PEG IL-2 microspheres.

    • Main Results:

    • Microsphere formulations were successfully prepared for PEG IL-2.
    • A formulation using HSA released 2-3% of PEG IL-2 daily after an initial burst.
    • Continuous, bioactive release of PEG IL-2 was observed over a 20- to 30-day period.
    • The microspheres demonstrated controlled release of modified IL-2.

    Conclusions:

    • Biodegradable microspheres are a viable platform for the controlled release of modified IL-2.
    • Sustained delivery of bioactive PEG IL-2 is achievable using this formulation.
    • This approach holds potential for optimizing IL-2 based immunotherapies.